CBE4
If you have any question, please contact technical support crispr@genscript.com.
| RC00011 | |
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
If you have any question, please contact technical support crispr@genscript.com.
| RC00011 | |
|
|
|
|
|
|
| Ask us a question | |
CBE4 is a custom-engineered fusion protein consisting of APOBEC3A, nCas9 (Cas9 nickase), and a nuclear localization signal (NLS). Designed as a cytidine base editor, it enables programmable, site-specific C-to-T conversions in genomic DNA, without inducing double-strand breaks (DSBs). |
|
• Gene Correction: Precisely convert
pathogenic C•G to T•A mutations in genetic disease models. • Disease Modeling: Generate cell lines or organoids harboring specific single-nucleotide variants (SNVs). • Preclinical Gene Therapy Research: Evaluate the safety and efficiency of base-editing as an alternative to DSB-mediated genome editing. • Screening & Library Generation: Construct targeted mutation libraries for drug screening or protein evolution. |
| Expression System | E.coli |
| Species | S. pyogenes |
| PAM | NGG |
| Tag | C-His tag |
| Molecular Weight | ~ 210 KDa |
| Storage & Stability | CBE4 is supplied with storage buffer (50 mM Tris, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% Glycerol pH7.5, at 25°C) and recommended to be stored at -80°C. |
| Purity | ≥90% by SDS-PAGE, 99% by SEC-HPLC |
| Concentration | ~ 10mg/mL |
| Residual DNase | Non-specific DNase activity |
| Endotoxin Level | <10 EU/mg |
| Exonuclease | No detection |
Fig.1 SDS-PAGE analysis of CBE4
Lane M: Protein Marker
Lane BSA: 2.00 ug BSA
Lane CBE4: CBE4 under reducing condition »
Fig.2 SEC-HPLC analysis of CBE4 »
| References |
1. Heller M, Prigge ES, Kaczorowski A, von
Knebel Doeberitz M, Hohenfellner M, Duensing S. APOBEC3A Expression in Penile
Squamous Cell Carcinoma. Pathobiology. 2018;85(3):169-178. doi:
10.1159/000479007. Epub 2017 Nov 23. PMID: 29166639. 2. Koblan, L., Doman, J., Wilson, C. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36, 843–846 (2018). https://doi.org/10.1038/nbt.4172 3. Yu, Y., Leete, T.C., Born, D.A. et al. Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. Nat Commun 11, 2052 (2020). https://doi.org/10.1038/s41467-020-15887-5 |
For
laboratory research use only. Direct human use, including taking orally,
injection and clinical use, are forbidden.